Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmather Holdings Ltd PHRRF


Primary Symbol: C.PHRM

psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:PHRM)

PharmaTher Announces Update on FDA New Drug Application for Ketamine

GlobeNewswire 5 days ago

PharmaTher Announces Post Complete Response Letter Clarification Meeting Request Granted from the FDA for Ketamine Abbreviated New Drug Application

GlobeNewswire 11 days ago

Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke

GlobeNewswire 12 days ago

PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application

GlobeNewswire October 23, 2024

PharmaTher Announces Update on FDA New Drug Application for Ketamine

GlobeNewswire September 4, 2024

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Newsfile August 28, 2024

PharmaTher's Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

GlobeNewswire August 21, 2024

PharmaTher's Sairiyo Therapeutics Receives Approval to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)

GlobeNewswire August 19, 2024

PharmaTher's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine

GlobeNewswire May 15, 2024
View More News ››

Opinion & Analysis (CSE:PHRM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:PHRM)

RE:Great NEWS!!!!

The meeting is good I guess, maybe should have happened long ago if they weren't confident with their submissions. But this is a...
Itistoo - 11 days ago

Approval Soon!!! Not If, but When

Still a buy at these levels, key factors: Very low shares outstanding 88mm, no debt, CEO has 19% of shares and been accumulating last 2-3...
Guytorule - 11 days ago

Great NEWS!!!!

FDA approved a face-face meeting addressing the CRL response to those minor difiencies. It works for everyones benefit to avoid back and...
Guytorule - 11 days ago

Nice Open..Volume Up with Buying!!

Picked up another 50K of shares this morning, nice open with large buying momentive. Soon we shall get positive news on company response...
Guytorule - November 4, 2024

RE:Market Depth...

Don't pay too much attention to the "BID" side of the orders. large and and even small participant BUYERS comes in with...
Guytorule - November 3, 2024

Market Depth...

See current market depth as of last Friday close for PHRM:  Very thin ASKS up to .40 cents, image FDA approved announcent will send...
Guytorule - November 3, 2024
View more Bullboard ››

GMV Minerals Inc

GMV Minerals Inc

GMV Minerals Inc. is an exploration company focused on developing precious metal assets in Arizona. The Company, through its ...
View More »